Literature DB >> 23982343

The missing "link": an autosomal recessive short stature syndrome caused by a hypofunctional XYLT1 mutation.

Julia Schreml1, Burak Durmaz, Ozgur Cogulu, Katharina Keupp, Filippo Beleggia, Esther Pohl, Esther Milz, Mahmut Coker, Sema Kalkan Ucar, Gudrun Nürnberg, Peter Nürnberg, Joachim Kuhn, Ferda Ozkinay.   

Abstract

Proteoglycan (PG) synthesis begins with the sequential addition of a "linker chain", made up of four sugar residues, to a specific region of a core protein. Defects in the enzymes catalyzing steps two to four of the linker chain synthesis have been shown to cause autosomal recessive human phenotypes while no mutation has yet been reported in humans for the xylosyltransferases 1 and 2 (XT1 and XT2), the initiating enzymes in the linker chain formation. Here, we present a consanguineous Turkish family with two affected individuals presenting with short stature, distinct facial features, alterations of fat distribution, and moderate intellectual disability. X-rays showed only mild skeletal changes in the form of a short femoral neck, stocky and plump long bones and thickened ribs. Using a combination of whole-exome sequencing (WES), determination of homozygous stretches by WES variants, and classical linkage analysis, we identified the homozygous missense mutation c.C1441T in XYLT1, encoding XT1, within a large homozygous stretch on chromosome 16p13.12-p12.1. The mutation co-segregated with the phenotype in the family, is not found in over 13,000 alleles in the exome variant server and is predicted to change a highly conserved arginine at position 481 (p.R481W) located in the putative catalytical domain. Immunostaining of primary patient fibroblasts showed a loss of predominance of Golgi localization in mutant cells. Moreover, western blot analysis of decorin in cell culture supernatant demonstrated glycosylation differences between patient and control cells. Our data provide evidence that functional alterations of XT1 cause an autosomal recessive short stature syndrome associated with intellectual disability.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23982343     DOI: 10.1007/s00439-013-1351-y

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  40 in total

1.  GRR: graphical representation of relationship errors.

Authors:  G R Abecasis; S S Cherny; W O Cookson; L R Cardon
Journal:  Bioinformatics       Date:  2001-08       Impact factor: 6.937

2.  A genetic defect in the biosynthesis of dermatan sulfate proteoglycan: galactosyltransferase I deficiency in fibroblasts from a patient with a progeroid syndrome.

Authors:  E Quentin; A Gladen; L Rodén; H Kresse
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

Review 3.  Influence of core protein sequence on glycosaminoglycan assembly.

Authors:  J D Esko; L Zhang
Journal:  Curr Opin Struct Biol       Date:  1996-10       Impact factor: 6.809

4.  Xylosylation of alternatively spliced isoforms of Alzheimer APP by xylosyltransferase.

Authors:  C Götting; J Kuhn; T Brinkmann; K Kleesiek
Journal:  J Protein Chem       Date:  1998-04

Review 5.  The molecular diversity of glycosaminoglycans shapes animal development.

Authors:  Hannes E Bülow; Oliver Hobert
Journal:  Annu Rev Cell Dev Biol       Date:  2006       Impact factor: 13.827

6.  Expression of the APP gene family in brain cells, brain development and aging.

Authors:  R Sandbrink; U Mönning; C L Masters; K Beyreuther
Journal:  Gerontology       Date:  1997       Impact factor: 5.140

7.  Determination of xylosyltransferase activity in serum with recombinant human bikunin as acceptor.

Authors:  C Weilke; T Brinkmann; K Kleesiek
Journal:  Clin Chem       Date:  1997-01       Impact factor: 8.327

8.  Biochemical and thermodynamic characterization of mutated β1,4-galactosyltransferase 7 involved in the progeroid form of the Ehlers-Danlos syndrome.

Authors:  Sophie Rahuel-Clermont; Franck Daligault; Marie-Helene Piet; Sandrine Gulberti; Patrick Netter; Guy Branlant; Jacques Magdalou; Virginie Lattard
Journal:  Biochem J       Date:  2010-12-01       Impact factor: 3.857

9.  Increased levels of xylosyltransferase I correlate with the mineralization of the extracellular matrix during osteogenic differentiation of mesenchymal stem cells.

Authors:  Benjamin Müller; Christian Prante; Martin Gastens; Joachim Kuhn; Knut Kleesiek; Christian Götting
Journal:  Matrix Biol       Date:  2007-10-09       Impact factor: 11.583

10.  UDP-D-xylose: proteoglycan core protein beta-D-xylosyltransferase: a new marker of cartilage destruction in chronic joint diseases.

Authors:  K Kleesiek; R Reinards; J Okusi; B Wolf; H Greiling
Journal:  J Clin Chem Clin Biochem       Date:  1987-08
View more
  31 in total

Review 1.  Advances in Skeletal Dysplasia Genetics.

Authors:  Krista A Geister; Sally A Camper
Journal:  Annu Rev Genomics Hum Genet       Date:  2015-04-22       Impact factor: 8.929

2.  Skeletal dysplasia in a consanguineous clan from the island of Nias/Indonesia is caused by a novel mutation in B3GAT3.

Authors:  Birgit S Budde; Shuji Mizumoto; Ryo Kogawa; Christian Becker; Janine Altmüller; Holger Thiele; Franz Rüschendorf; Mohammad R Toliat; Gerrit Kaleschke; Johannes M Hämmerle; Wolfgang Höhne; Kazuyuki Sugahara; Peter Nürnberg; Ingo Kennerknecht
Journal:  Hum Genet       Date:  2015-04-19       Impact factor: 4.132

3.  GGC Repeat Expansion and Exon 1 Methylation of XYLT1 Is a Common Pathogenic Variant in Baratela-Scott Syndrome.

Authors:  Amy J LaCroix; Deborah Stabley; Rebecca Sahraoui; Margaret P Adam; Michele Mehaffey; Kelly Kernan; Candace T Myers; Carrie Fagerstrom; George Anadiotis; Yassmine M Akkari; Katherine M Robbins; Karen W Gripp; Wagner A R Baratela; Michael B Bober; Angela L Duker; Dan Doherty; Jennifer C Dempsey; Daniel G Miller; Martin Kircher; Michael J Bamshad; Deborah A Nickerson; Heather C Mefford; Katia Sol-Church
Journal:  Am J Hum Genet       Date:  2018-12-13       Impact factor: 11.025

4.  Novel and recurrent XYLT1 mutations in two Turkish families with Desbuquois dysplasia, type 2.

Authors:  Long Guo; Nursel H Elcioglu; Aritoshi Iida; Yasemin K Demirkol; Seda Aras; Naomichi Matsumoto; Gen Nishimura; Noriko Miyake; Shiro Ikegawa
Journal:  J Hum Genet       Date:  2016-11-24       Impact factor: 3.172

5.  Xylose phosphorylation functions as a molecular switch to regulate proteoglycan biosynthesis.

Authors:  Jianzhong Wen; Junyu Xiao; Meghdad Rahdar; Biswa P Choudhury; Jixin Cui; Gregory S Taylor; Jeffrey D Esko; Jack E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-20       Impact factor: 11.205

6.  Homozygosity for frameshift mutations in XYLT2 result in a spondylo-ocular syndrome with bone fragility, cataracts, and hearing defects.

Authors:  Craig F Munns; Somayyeh Fahiminiya; Nabin Poudel; Maria Cristina Munteanu; Jacek Majewski; David O Sillence; Jordan P Metcalf; Andrew Biggin; Francis Glorieux; François Fassier; Frank Rauch; Myron E Hinsdale
Journal:  Am J Hum Genet       Date:  2015-05-28       Impact factor: 11.025

7.  XYLT1 mutations in Desbuquois dysplasia type 2.

Authors:  Catherine Bui; Céline Huber; Beyhan Tuysuz; Yasemin Alanay; Christine Bole-Feysot; Jules G Leroy; Geert Mortier; Patrick Nitschke; Arnold Munnich; Valérie Cormier-Daire
Journal:  Am J Hum Genet       Date:  2014-02-27       Impact factor: 11.025

8.  News on Clinical Details and Treatment in PGM1-CDG.

Authors:  Esther Schrapers; Laura C Tegtmeyer; Gunter Simic-Schleicher; Volker Debus; Janine Reunert; Sebastian Balbach; Karin Klingel; Ingrid Du Chesne; Anja Seelhöfer; Manfred Fobker; Thorsten Marquardt; Stephan Rust
Journal:  JIMD Rep       Date:  2015-08-25

9.  Exome sequencing reveals two novel compound heterozygous XYLT1 mutations in a Polish patient with Desbuquois dysplasia type 2 and growth hormone deficiency.

Authors:  Aleksander Jamsheer; Ewelina M Olech; Kazimierz Kozłowski; Marek Niedziela; Anna Sowińska-Seidler; Monika Obara-Moszyńska; Anna Latos-Bieleńska; Marek Karczewski; Tomasz Zemojtel
Journal:  J Hum Genet       Date:  2016-03-31       Impact factor: 3.172

10.  Forward genetics defines Xylt1 as a key, conserved regulator of early chondrocyte maturation and skeletal length.

Authors:  Emily K Mis; Karel F Liem; Yong Kong; Nancy B Schwartz; Miriam Domowicz; Scott D Weatherbee
Journal:  Dev Biol       Date:  2013-10-23       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.